What's The BUZZ?

Market News, Products, Services, and Trends

ProRx Pharma News & Announcements

ProRx Pharma is an FDA-registered 503B facility focused on providing essential compounded sterile and non-sterile preparations. The company compounds products and formulations for medical institutions, physician offices, and 503A pharmacies, with a specialization in producing high-quality products to ensure patients have access to the medications they need during critical shortages.

ProRx Pharma Continues to Grow Operational Footprint, Triples Production Capacity to Support Demand for Compounded Medications
Press Releases
Author

ProRx Pharma Continues to Grow Operational Footprint, Triples Production Capacity to Support Demand for Compounded Medications

Longevity Is No Longer Fringe Medicine. It’s Operational Medicine.
Press Releases
Author

Longevity Is No Longer Fringe Medicine. It’s Operational Medicine.

ProRx Pharma Redefines Hormone Therapy with Needle-Free Oral Testosterone Option
Press Releases
Author

ProRx Pharma Redefines Hormone Therapy with Needle-Free Oral Testosterone Option

ProRx Pharma Redefines NAD+ Delivery with New Oral System for Medical Clinics
Press Releases
Author

ProRx Pharma Redefines NAD+ Delivery with New Oral System for Medical Clinics

What You Need to Know About ProRx Pharma
Author

What You Need to Know About ProRx Pharma

Why Peptides Are Back in the News
Press Releases
Author

Why Peptides Are Back in the News

What Medical Clinics Really Want From a 503B Partner in 2026: Reliability, Consistency, and Alignment
Press Releases
Author

What Medical Clinics Really Want From a 503B Partner in 2026: Reliability, Consistency, and Alignment

Why Facility Upgrades Matter in 503B Outsourcing
Press Releases
Author

Why Facility Upgrades Matter in 503B Outsourcing

Oral NAD+: Why Delivery Is Becoming the Defining Question in Cellular Health
Press Releases
Author

Oral NAD+: Why Delivery Is Becoming the Defining Question in Cellular Health

The Most Important Shift in Compounding for 2026 Isn’t a New Medication
Press Releases
Author

The Most Important Shift in Compounding for 2026 Isn’t a New Medication

Why the Difference Between Sterile and Non-Sterile Compounding Matters
Press Releases
Author

Why the Difference Between Sterile and Non-Sterile Compounding Matters

Wellness Backed by Science: The Potential Benefits of MIC+B1/B12 Injections
Press Releases
Author

Wellness Backed by Science: The Potential Benefits of MIC+B1/B12 Injections

What Is NAD+ and Why Are So Many People Talking About It?
Press Releases
Author

What Is NAD+ and Why Are So Many People Talking About It?

Hormone Health in Focus: Why Women’s HRT Is Evolving and What It Means for Personalized Care
Press Releases
Author

Hormone Health in Focus: Why Women’s HRT Is Evolving and What It Means for Personalized Care

What You’re Getting Wrong about Drug Compounding: Clearing up the Misconceptions
Press Releases
Author

What You’re Getting Wrong about Drug Compounding: Clearing up the Misconceptions

What You’re Getting Wrong about Drug Compounding: Clearing up the Misconceptions
Press Releases
Author

What You’re Getting Wrong about Drug Compounding: Clearing up the Misconceptions

Ensuring Compliance with 503B State Licensing Requirements
Press Releases
Author

Ensuring Compliance with 503B State Licensing Requirements

Personalized Medicine and the Critical Role of 503B Outsourcing Facilities
Press Releases
Author

Personalized Medicine and the Critical Role of 503B Outsourcing Facilities

How ProRx Pharma Ensures Quality, Safety, and Confidence Through Stability Studies and Beyond-Use Dates
Press Releases
Author

How ProRx Pharma Ensures Quality, Safety, and Confidence Through Stability Studies and Beyond-Use Dates

ProRx Pharma Expands State-of-the-Art Facilities to Fuel Growing Demand for Personalized and Preventative Medicine
Press Releases
Author

ProRx Pharma Expands State-of-the-Art Facilities to Fuel Growing Demand for Personalized and Preventative Medicine

ProRx Introduces New Liquid Nanoemulsion Delivery System to Support Enhanced Absorption, Bioavailability, and Patient Convenience
Press Releases
Author

ProRx Introduces New Liquid Nanoemulsion Delivery System to Support Enhanced Absorption, Bioavailability, and Patient Convenience

ProRx Pharma Awarded DEA Controlled Substances Registration Certificate
Press Releases
Author

ProRx Pharma Awarded DEA Controlled Substances Registration Certificate

ProRx Statement Regarding FDA Inspection
Press Releases
Author

ProRx Statement Regarding FDA Inspection

ProRx Pharma Highlights the Role of 503B Compounders in Personalized Care During National Wellness Month
Press Releases
Author

ProRx Pharma Highlights the Role of 503B Compounders in Personalized Care During National Wellness Month

ProRx Pharma and Gatlan Announce Exclusive Partnership to Enhance Men’s Access to Health and Wellness Products
Press Releases
Author

ProRx Pharma and Gatlan Announce Exclusive Partnership to Enhance Men’s Access to Health and Wellness Products

ProRx Pharma Continues to Expand Preventative Health Portfolio with Six New Products
Press Releases
Author

ProRx Pharma Continues to Expand Preventative Health Portfolio with Six New Products

ProRx Pharma Launches Preventative Health Line with Four New Products
Press Releases
Author

ProRx Pharma Launches Preventative Health Line with Four New Products

ProRx Pharma Expands Production to Address Demand for Drugs on FDA Shortage List
Press Releases
Author

ProRx Pharma Expands Production to Address Demand for Drugs on FDA Shortage List

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from YARAL Pharma Launches 15-Count Diclofenac Epolamine Topical System 1.3%, Offering Pharmacists a Flexible, Space-Saving Option

Name
Address
Subscribe